<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00538421</url>
  </required_header>
  <id_info>
    <org_study_id>S-07294b (REK)</org_study_id>
    <secondary_id>2007-000002-79 (Eudract)</secondary_id>
    <secondary_id>17089 (NSD)</secondary_id>
    <nct_id>NCT00538421</nct_id>
  </id_info>
  <brief_title>Opioid-potentiated Volative Anaesthetic Vs. Remifentanil And Propofol During Abdominal Aortic Aneurysm Surgery</brief_title>
  <acronym>ABSENT</acronym>
  <official_title>Opioid-potentiated Volative Anaesthetic(Sevoflurane)Compared to Remifentanil and Propofol During Abdominal Aortic Aneurysm Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sykehuset i Vestfold HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sykehuset i Vestfold HF</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing 2 different anaesthetic methods during abdominal aortic aneurysm surgery. The
      patients will be followed up 30 days postoperative. Number of patients included will be 200.
      Perioperative details will be analyzed.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2008</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">February 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">193</enrollment>
  <condition>Aortic Diseases</condition>
  <condition>Abdominal</condition>
  <condition>Aneurysm</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Infusion intravenously (IV) 0-10 mg/kg/h</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>0,7-1,5 MAC</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are planned for open, elective abdominal aortic aneurysm surgery.

          -  ASA group 1-4.

        Exclusion Criteria:

          -  Patients below 18 years.

          -  Patients who are included in other pharmaceutical studies.

          -  Opioids-, benzodiazepins-, antiepileptic drugs-, alcohol- and Î±2-agonists abuse.

          -  Pregnant and breastfeeding women.

          -  Patients with familiar history of malignant hyperthermia.

          -  Patients with known hypersensitivity for opioids, propofol or volative anaesthetics.

          -  Patients with considerable arrythmia (atrial fibrillation /atrial flutter is
             acceptable). Uncontrolled hypertension, serious psychiatric disease.

          -  Patients with unstable angina pectoris or myocardial infarction last month before
             inclusion.

          -  Acute abdominal aortic surgery. Acute dissection or rupture.

          -  Planned laparoscopic abdominal aortic aneurysm surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Espen Lindholm, MD</last_name>
    <role>Study Director</role>
    <affiliation>Sykehuset i Vestfold HF</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sykehuset i Vestfold HF</name>
      <address>
        <city>Tonsberg</city>
        <zip>3103</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2007</study_first_submitted>
  <study_first_submitted_qc>October 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2007</study_first_posted>
  <last_update_submitted>March 8, 2013</last_update_submitted>
  <last_update_submitted_qc>March 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sykehuset i Vestfold HF</investigator_affiliation>
    <investigator_full_name>Espen Lindholm</investigator_full_name>
    <investigator_title>Chief consultant</investigator_title>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>Anaesthesia</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Abdominal</keyword>
  <keyword>Aortic</keyword>
  <keyword>Aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Aortic Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

